Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing lamivudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine + zidovudine 150mg/300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abacavir sulfate + lamivudine + zidovudine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine + zidovudine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing abacavir and lamivudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abacavir- and lamivudine- and zidovudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine- and nevirapine- and zidovudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lamivudine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lamivudine and nevirapine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abacavir- and lamivudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine- and nevirapine- and stavudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine- and zidovudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing abacavir and dolutegravir and lamivudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Abacavir- and lamivudine- and zidovudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
Has precise active ingredient |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 100 mg oral tablet |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
Has precise active ingredient |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 300 mg oral tablet |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has precise active ingredient |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Abacavir and lamivudine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only abacavir and lamivudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Abacavir and dolutegravir and lamivudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only abacavir and lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine- and stavudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine and nevirapine and stavudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine and nevirapine and zidovudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lamivudine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine and stavudine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only lamivudine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only doravirine and lamivudine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing doravirine and lamivudine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing doravirine and lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only doravirine and lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dolutegravir- and lamivudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolutegravir and lamivudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lamivudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |